Pipeline
Phase III Clinical Trials (updated 1/6/2012)
|
Description
|
Protocol |
IND # |
| A Randomized Phase III Study of Combination Antineoplaston Therapy [Antineoplaston A10 (Atengenal) and AS2-1 (Astugenal)] Plus Radiation Therapy vs. Radiation Therapy Alone in Subjects with Newly Diagnosed, Diffuse, Intrinsic Brain Stem Glioma. |
BRI-BT-50 |
43,742 |
Phase II Clinical Trials (updated 1/6/2012)
|
Description
|
Protocol |
IND # |
| PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH BRAIN TUMORS. |
BRI-BT-10 |
43,742 |
|
